Winslow Evans & Crocker’s Kite Pharma, Inc. KITE Stock Holding History

Winslow Evans & Crocker’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-800	Closed	-$144K	–	1178
2017 Q3	$144K	Sell	800 -400	-33%	-$55.7K	0.05%	299
2017 Q2	$124K	Buy	+1,200	New	+$97.9K	0.03%	390

Winslow Evans & Crocker's KITE Position: Q4 2017 in Review

Winslow Evans & Crocker sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 800 shares — an estimated $144K sold.

Winslow Evans & Crocker first reported a position in KITE in Q2 2017 and held it in 2 quarters. The position peaked at $144K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Winslow Evans & Crocker reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Winslow Evans & Crocker sold 800 Kite Pharma, Inc. shares in Q4 2017, an estimated $144K.
Winslow Evans & Crocker first reported a position in Kite Pharma, Inc. in Q2 2017 and held it in 2 quarters.
Winslow Evans & Crocker's Kite Pharma, Inc. position peaked at $144K in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Winslow Evans & Crocker's 13F filing for Q4 2017, filed 19 Jan 2018.